Filing Details
- Accession Number:
- 0001599901-25-000131
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-18 18:02:48
- Reporting Period:
- 2025-06-17
- Filing Date:
- 2025-06-18
- Accepted Time:
- 2025-06-18 18:02:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1599901 | Avidity Biosciences Inc. | RNA | Pharmaceutical Preparations (2834) | 461336960 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2048409 | P. Kathleen Gallagher | C/O Avidity Biosciences, Inc. 10578 Science Center Dr., Suite 125 San Diego CA 92121 | Chief Program Officer | No | Yes | No | No |
Transaction Summary
| Sold: | 911 shares | Avg. Price: $30.24 | Total Value: $27,548.64 |
| Number of Shares After Transactions: | 50,392 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-06-17 | 911 | $30.24 | 50,392 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.
Billionaire Hedge Funds
